Guidance Notes

View the directory of Guidance Notes written by our experts, and covering topics requested by members. Access is free, although you will need to register to be able to view the content.

  • Specialism

  • Lifecycle Stage

GNT 75: Regulatory Activities and R&D Tax Incentives

GNES 14: Neurodiversity in Life Sciences: A Roadmap for Inclusion and Innovation

GNT 74: Research Intensive Companies

GNT 73: Restriction on Overseas R&D Activities

GNP:7 AI in life sciences: possible effects of AI on patentability of certain inventions

GNP: 6 Patenting AI and machine learning inventions at the EPO

GNES 13: The Employer Branding Emergency

GNP 5: Unified Patent Court and Unitary Patent in Europe

GNP 4: Patent Filing Strategies

GNP 3: Pros and Cons of Filing a Patent

GNP 2: Patent Fundamentals

GNP 1: Intellectual Property Basics

GNES 12: Recruitment – Is it still about Cultural Fit?

GNL 41: Preliminary injunctive relief in patent disputes

GNES 11: Importance of Autonomy

GNMA 10: Policy and public affairs for life science companies

GNMA 9: Supranational HTAs

GNES 10: Employee Wellness Within a Hybrid Working Model

GNX 12: Getting your voice heard by big pharma

GNL 40: Flexible remedies in life science patent disputes

GNL 39: Changes to data exclusivity

GNT 72: Tax treatment of interest on convertible loans

GNT 71: Corporate Interest Restriction (CIR)

GNMA 8: Market access for medtech, diagnostics and digital technologies in the UK

GNES 9: Reinvention during and after COVID- will company culture stand the test of time?

GNX 11: Using Independent Expert Reports for an IPO

GNL 38: Product liability – what is a “defect”?

GNL37: UK experimental use exemptions

GNT 70: Working from Home (in the UK and abroad) – Common Tax Concerns

GNT 69: Making Tax Digital for Corporation Tax

Sign-Up For Free

Sign-up to receive up-to-date information and advice on tax developments within your industry.

Sign-up for free